NEXT Oncology Blog

Your NEXT Option™
May 2, 2023

Video: Expanded Phase 1 Program to the Dallas Area

Featured image for “Video: Expanded Phase 1 Program to the Dallas Area”

Latest

See All
May 2, 2023

SA cancer research company entering Dallas market as it eyes more U.S., European expansion

Featured image for “SA cancer research company entering Dallas market as it eyes more U.S., European expansion”
April 14, 2023

NEXT Oncology Expands Phase I Program to Dallas Area

Featured image for “<strong>NEXT Oncology Expands Phase I Program to Dallas Area</strong>”
January 9, 2023

Grand Opening of joint venture brings access to proprietary Phase I program to more patients

November 1, 2022

Teon Therapeutics Announces First Patient Treated in Phase 1/2 Clinical Trial of TT-816, a Novel Oral Immune Checkpoint Inhibitor, in Patients with Advanced Solid Tumors

Featured image for “Teon Therapeutics Announces First Patient Treated in Phase 1/2 Clinical Trial of TT-816, a Novel Oral Immune Checkpoint Inhibitor, in Patients with Advanced Solid Tumors”

© NEXT Oncology - Your NEXT Option™

2829 Babcock Road Suite 300, San Antonio, Texas 78229

Call Now Button